Document is current
Any future updates will be listed below
-
Authors
Falana, Sadia L.
Kazmouz, Sobhi G.
Iwanski, Jessika B.
Sarvagalla, Sailu
Bas, Blaire E.
Juneman, Elizabeth
Moukabary, Talal https://orcid.org/0000-0001-6557-6404
Ma, Ning https://orcid.org/0000-0002-1775-2992
Gundry, Rebekah L. https://orcid.org/0000-0002-9263-833X
Rohani, Leili
Hanson, Paul
Laksman, Zachary
James, Cynthia A. https://orcid.org/0000-0001-8040-4600
Calkin, Hugh
Churko, Jared M. https://orcid.org/0000-0003-3537-9834
- License Information
-
More Information
Article History
Received: 30 November 2023
Accepted: 23 September 2025
First Online: 27 October 2025
Competing interests
: C.A.J. has received research funding from Tenaya Therapeutics, Lexeo Therapeutics, Rocket Pharmaceuticals, ARVADA Therapeutics, StrideBio Inc., and EicOsis, Inc., and has served as a past consultant for Lexeo Therapeutics. HC has received research support from Tenaya Therapeutics, EicOsis Inc., and Stride Bio. All other authors declare no competing interests.
